ETHANOLIC RESINIFERATOXIN CONCENTRATE

Abstract: the invention relates to a liquid pharmaceutical concentrate comprising or essentially consisting of resiniferatoxin in an amount of less than 3.20 �g, preferably at most 900 ng, more preferably at most 700 ng and ethanol. the composition according to the invention is particularly useful for the treatment of pain due to knee osteoarthritis. prior to administration, the concentrate is diluted with a dilution liquid, preferably an aqueous dilution liquid, thereby obtaining a diluted composition, preferably a diluted solution. said diluted composition or a partial volume thereof is subsequently administered as dose unit, preferably by intraarticular injection into the knee.

Inventor(s): Marc SCHILLER

CPC Classification: A61K9/08 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))

Search for rejections for patent application number 20250228775